CD66b+ Neutrophils and Α-Sma+ Fibroblasts Predict Clinical Outcomes and Benefits From Postoperative Chemotherapy in Gastric Adenocarcinoma
Cancer Medicine - United Kingdom
doi 10.1002/cam4.2939
Full Text
Open PDFAbstract
Available in full text
Date
February 25, 2020
Authors
Publisher
Wiley